National Heart, Lung, and Blood Institute

Bethesda, Maryland 20892

We've found

3 trials

at this facility

Validation of Coronary Calcium Subtraction to Improve Diagnostic Accuracy of Coronary CT Angiography

Status: Enrolling
Updated: 10/11/2015

from

Bethesda, MD

Targeted Therapy in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myelogenous Leukemia

Status: Enrolling, Phase II
Updated: 12/1/2016

from

Bethesda, MD

Clofazimine in the Treatment of Pulmonary Mycobacterium Avium Complex (MAC)

Status: Enrolling, Phase II
Updated: 12/31/1969

from

Bethesda, MD

Use our guide to learn which trials are right for you!